Biotechnology

Biotech Conagen Acquires Production Platform of Therapeutic Proteins

The technology should reduce costs to patients and accelerate drug development   BEDFORD, Massachusetts, Aug. 22, 2019 /PRNewswire/ -- Conagen, a vertically integrated synthetic biology company located inBoston's biotech corridor, announced today that it has acquired a fermentation-based technolo...

2019-08-22 01:39 1427

CMAB and Kintor Announce a New Comprehensive Collaboration to Develop and Manufacture the ALK-1 Monoclonal Antibody

* This agreement represents the first strategic cooperation between two of the key players in biopharmaceutical industries in Suzhou,China * ALK-1 (Activin receptor-like kinase-1) antibody was originally developed by Pfizer who completed two Phase I clinical trials in more than 100 patients wi...

2019-08-21 21:35 2237

Global Cord Blood Corporation to Report First Quarter Fiscal 2020 Financial Results

HONG KONG, Aug. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company") today announced that it plans to release financial results for the first quarter fiscal 2020 onTuesday, August 27, 2019, after the market close.  The Company will host a conference call at 8:00 a.m....

2019-08-21 19:00 6856

NeuroVive Pharmaceutical AB Interim Report January - June 2019

STOCKHOLM, Aug. 21, 2019 /PRNewswire/ -- Important events April - June * The US Food and Drug Administration, FDA, approves NeuroVive's IND (Investigational New Drug) application, enabling clinical studies in the US with the company's drug candidate NeuroSTAT. * The Supreme Court delivers it...

2019-08-21 15:24 6738

Conagen Expands Portfolio Beyond Gamma-Decalactone to 20 new non-GMO Lactones

Customers Choose from a Wider Spectrum of Flavor Profiles  BOSTON, Aug. 13, 2019 /PRNewswire/ -- Conagen, a Boston-based biotechnology company focusing on research and development, announced today its breakthrough development in the commercial production of natural aromatic compound, γ-Decalact...

2019-08-13 03:47 1796

Higher Levels of Automation Expand Revenue Potential for Analytical Instrumentation Manufacturers

Pharmaceuticals, biotechnology, and academics emerge major adopters of analytical equipment, finds Frost & Sullivan SANTA CLARA, California, Aug. 13, 2019 /PRNewswire/ -- The rise of the Industrial Internet of Things (IIoT) has given a significant boost to the global analytical instrumentation ma...

2019-08-13 00:19 1848

OssDsign AB (publ) Initiates Commercial Preparations for Launch in Japan Following Regulatory Filing for OssDsign Cranial

STOCKHOLM, Aug. 9, 2019 /PRNewswire/ -- OssDsign AB (publ) ("OssDsign" or the "Company"), the Swedish designer and manufacturer of innovative implants for bone regeneration, has filed for a Japanese regulatory approval of OssDsign Cranial. Subsequent to the filing, OssDsign initiates commercial p...

2019-08-09 14:57 1360

DiscGenics Announces First Patients Treated in Japanese Clinical Trial of Cell Therapy for Degenerative Disc Disease

SALT LAKE CITY, Aug. 7, 2019 /PRNewswire/ -- DiscGenics, Inc., a clinical stage biotechnology company focused on developing regenerative cell-based therapies that alleviate pain and restore function in patients with degenerative diseases of the spine, today announced the first patients have been ...

2019-08-07 21:00 1272

Corteva Agriscience Launches in Myanmar to Serve Farmers Better with the Newest Innovation in Seed and Crop Protection Technologies

YANGON, Myanmar, Aug. 7, 2019 /PRNewswire/ -- Pure-play global agriculture leader, Corteva Agriscience (NYSE:CTVA), has officially launched its brand in Myanmar. In conjunction with the brand launch, the company also introduced Zorvec® Encantia® fungicide - a new international award-winning diseas...

2019-08-07 10:30 7081

LUCA Biologics Launches to Develop Live Biotherapeutics for Women's Health Starting with Urinary Tract Infection (UTI)

CAMBRIDGE, Massachusetts, Aug. 6, 2019 /PRNewswire/ -- LUCA Biologics, a biotechnology company co-founded by Dr.Jacques Ravel, announced today it will develop live biotherapeutics for widespread, unmet medical needs in women's health. Ravel will serve as LUCA's Chief Scientist. The company's fir...

2019-08-06 18:00 1595

Ascletis Received IND Approval and Management Outlook of 2019 and Beyond

HANGZHOU and SHAOXING, China, Aug. 5, 2019 /PRNewswire/ -- Ascletis Pharma Inc. (1672.HK), an innovative R&D driven, commercial-stage biotechnology company addressing unmet medical needs in therapeutic areas including anti-viral, cancer and fatty liver diseases, announces today that it received I...

2019-08-05 08:00 1630

Biosyngen Group Attends SLETC and Signs Contract of Dalian Sino-Singapore Biotech Hub

SINGAPORE, Aug. 2, 2019 /PRNewswire/ -- On July 29, 2019, at the invitation of Dalian Municipal People's Government, Mr.Frank Wang, Chairman of Biosyngen Group and Dr.Victor Li, CEO of Biosyngen Group attended the 10th Singapore-Liaoning Economic and Trade Council (SLETC) meeting inShenyang and ...

2019-08-02 10:24 813

ERBA Mannheim to Unveil NEXUS Next Generation Automation at AACC 2019

LONDON, Aug.1, 2019 /PRNewswire/ -- * New affordable, modular, mid-scale clinical chemistry, immunoassay and hematology range with sample selection and transport systems, making powerful automation accessible to growing labs * Hematology system uses unique combination of ultra-high defi...

2019-08-01 04:39 1404

Submission and acceptance of application for the production of new drug for Yisaipu(R)aqueous injection solution

SHANGHAI, July 29, 2019 /PRNewswire/ -- 3SBio Inc. (01530.HK), a leading biopharmaceutical company in the PRC, announces today that an application for the production of new drug has been submitted to the National Medical Products Administration for Yisaipu® pre-filled aqueous injection solution (...

2019-07-29 21:42 4096

NeuroVive's NeuroSTAT Project Receives FDA Fast Track Designation

LUND, Sweden, July 28, 2019 /PRNewswire/ -- NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP) (OTCQX: NEVPF) today announced that the company's candidate drug NeuroSTAT, in development for treatment of moderate to severe traumatic brain injury, TBI, has received Fast Track designation from the ...

2019-07-28 21:47 4075

Penta and CROMSOURCE Announce Their Partnership to Improve Paediatric Drug Development

VERONA, Italy, July 25, 2019 /PRNewswire/ -- Penta ID Innovation, a recently established SMO stemmed from the Penta Global Paediatric Research Network, and CROMSOURCE, an international contract research organization (CRO) providing a comprehensive portfolio of services to the pharmaceutical, biot...

2019-07-25 19:00 1910

Mirae Asset Launches China Biotech and Cloud Computing themed ETFs in Hong Kong

HONG KONG, July 25, 2019 /PRNewswire/ -- Mirae Asset Global Investments (Hong Kong) Limited today is pleased to announce the launch of its 'Mirae Asset Horizons China Biotech ETF' and 'Mirae Asset Horizons China Cloud Computing ETF' inHong Kong, allowing investors to gain exposure to the vast pot...

2019-07-25 09:00 1704

Global Cord Blood Corporation Files Its Annual Report on Form 20-F

HONG KONG, July 24, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing, and stem cell storage services, today announced that the Company filed its Annual ...

2019-07-24 04:16 10385

WuXi STA Shanghai & Changzhou Facilities Pass U.S. FDA Inspections

SHANGHAI, July 23, 2019 /PRNewswire/ -- STA Pharmaceutical Co., Ltd., (WuXi STA) – a subsidiary of WuXi AppTec – announces that its Analytical Service Unit (ASU) inShanghai and active pharmaceutical ingredient (API) process R&D and manufacturing facility in Changzhou, have successfully passed two...

2019-07-23 12:48 1702

Yisheng Biopharma Receives GMP Certification from China NMPA for Production of Lyophilized Rabies Vaccine for Preventive Use

BEIJING, July 22, 2019 /PRNewswire/ -- Yisheng Biopharma Co., Ltd. ("Yisheng Biopharma"), a biopharmaceutical company focusing on research, development, manufacturing, sales and marketing of immunological biologics and vaccines, announced that its new rabies vaccine production facility has receiv...

2019-07-22 21:00 1506
12345678 ... 52